电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

COMMD9 抗体 (AA 1-198)

COMMD9 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
产品编号 ABIN7148320
发货至: 中国
  • 抗原 See all COMMD9 抗体
    COMMD9 (COMM Domain Containing 9 (COMMD9))
    抗原表位
    • 15
    • 8
    • 8
    • 6
    • 4
    AA 1-198
    适用
    • 21
    • 17
    宿主
    • 36
    克隆类型
    • 36
    多克隆
    标记
    • 8
    • 5
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This COMMD9 antibody is un-conjugated
    应用范围
    • 31
    • 19
    • 13
    • 13
    • 4
    • 3
    • 1
    ELISA, Immunohistochemistry (IHC)
    交叉反应
    纯化方法
    >95%, Protein G purified
    免疫原
    Recombinant Human COMM domain-containing protein 9 protein (1-198AA)
    亚型
    IgG
    Top Product
    Discover our top product COMMD9 Primary Antibody
  • 应用备注
    Recommended dilution: IHC:1:20-1:200,
    限制
    仅限研究用
  • 状态
    Liquid
    缓冲液
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    储存液
    ProClin
    注意事项
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    储存条件
    -20 °C,-80 °C
    储存方法
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 抗原
    COMMD9 (COMM Domain Containing 9 (COMMD9))
    别名
    COMMD9 (COMMD9 产品)
    别名
    1810029F08Rik antibody, AA409293 antibody, COMM domain containing 9 antibody, COMMD9 antibody, Commd9 antibody
    背景

    Background: May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes (PubMed:21778237). May down-regulate activation of NF-kappa-B (PubMed:15799966). Modulates Na(+) transport in epithelial cells by regulation of apical cell surface expression of amiloride-sensitive sodium channel (ENaC) subunits (PubMed:23637203).

    Aliases: COMD9_HUMAN antibody, COMM domain containing 9 antibody, COMM domain-containing protein 9 antibody, COMMD9 antibody, HSPC166 antibody

    UniProt
    Q9P000
You are here: